Follow
Bita Mesgarpour
Bita Mesgarpour
Associate Professor, National Institute for Medical Research Development (NIMAD), Tehran, Iran
Verified email at research.ac.ir
Title
Cited by
Cited by
Year
An epidemiological survey of psychiatric disorders in Iran
MR Mohammadi, H Davidian, AA Noorbala, H Malekafzali, HR Naghavi, ...
Clinical practice and epidemiology in mental health 1, 1-8, 2005
4072005
Prevalence of obsessive-compulsive disorder in Iran
MR Mohammadi, A Ghanizadeh, M Rahgozar, A Noorbala, H Davidian, ...
BMC psychiatry 4 (1), 2, 2004
1652004
Acupuncture or acupressure for pain management during labour
CA Smith, CT Collins, KM Levett, M Armour, HG Dahlen, AL Tan, ...
Cochrane Database of Systematic Reviews, 2020
1322020
Prevalence of social phobia and its comorbidity with psychiatric disorders in Iran
MR Mohammadi, A Ghanizadeh, M Mohammadi, B Mesgarpour
Depression and anxiety 23 (7), 405-411, 2006
672006
Prevalence of psychiatric disorders in Iran: A systematic review
A Farhoudian, V Sharifi, H Amini, A Basirnia, B Mesgarpour, N Mansouri, ...
IRANIAN JOURNAL OF PSYCHIATRY 2 (4), 137-150, 2007
552007
Prevalence of mood disorders in Iran
MR Mohammadi, ZA GHANI, H Davidian, AA NOURBALA, AH MALEK, ...
IRANIAN JOURNAL OF PSYCHIATRY 1 (2), 59-64, 2006
532006
Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial
MR Mohammadi, A Ghanizadeh, J Alaghband-Rad, M Tehranidoost, ...
Journal of Child & Adolescent Psychopharmacology 14 (3), 418-425, 2004
512004
Harms of off‐label erythropoiesis‐stimulating agents for critically ill people
B Mesgarpour, BH Heidinger, D Roth, S Schmitz, CD Walsh, H Herkner
Cochrane Database of Systematic Reviews, 2017
402017
Extended‐release opioids in the management of cancer pain: A systematic review of efficacy and safety
B Mesgarpour, U Griebler, A Glechner, C Kien, M Strobelberger, ...
European Journal of Pain 18 (5), 605-616, 2014
402014
L‐carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double‐blind study
S Arabzadeh, M Shahhossenie, B Mesgarpour, F Rezaei, MR Shalbafan, ...
Human Psychopharmacology: clinical and experimental 32 (4), e2584, 2017
382017
l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
R Hajizadeh-Zaker, A Ghajar, B Mesgarpour, M Afarideh, ...
Journal of child and adolescent psychopharmacology 28 (1), 74-81, 2018
372018
Epidemiological Study of Psychiatric Disorders in Tehran Province
MR Mohammadi, M Rahgozar, A Bagheri Yazdi, HR Naghavi, ...
Iranian Journal of Psychiatry and Clinical Psychology 9 (2(34)), 4-14, 2003
362003
Herbal medicine in Iran
HR Adhami, B Mesgarpour, H Farsam
Herbalgram 74, 34-43, 2007
342007
Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis
B Mesgarpour, BH Heidinger, M Schwameis, C Kienbacher, C Walsh, ...
Intensive care medicine 39, 1896-1908, 2013
302013
Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis
H Hatami, G Sotgiu, N Bostanghadiri, SSD Abadi, B Mesgarpour, ...
Jornal Brasileiro de Pneumologia 48, e20210384, 2022
292022
Research assessment of Iranian medical universities, an experience from a developing country
E Habibi, B Mesgarpour, M Vasei
Iranian J Publ Health 38 (1), 47-9, 2009
292009
Health research system resilience: lesson learned from the COVID-19 crisis
B Yazdizadeh, R Majdzadeh, A Ahmadi, B Mesgarpour
Health Research Policy and Systems 18 (1), 136, 2020
282020
Interventions to improve adverse drug reaction reporting: a scoping review
M Khalili, B Mesgarpour, H Sharifi, S Daneshvar Dehnavi, AA Haghdoost
Pharmacoepidemiology and Drug Safety 29 (9), 965-992, 2020
282020
Comparative risk of harm associated with the use of targeted immunomodulators: a systematic review
RJ Desai, KJ Thaler, P Mahlknecht, G Gartlehner, MS McDonagh, ...
Arthritis Care & Research 68 (8), 1078-1088, 2016
282016
Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial
E Moazen-Zadeh, S Bayanati, K Ziafat, F Rezaei, B Mesgarpour, ...
Journal of Psychopharmacology 34 (5), 506-513, 2020
272020
The system can't perform the operation now. Try again later.
Articles 1–20